What’s going on?
Moderna has started to test three variations of a booster shot among 60 participants, the company said.
Moderna said it would start with a variant-specific jab, which will be given in a smaller dose than the original vaccine. This will be done to make sure that the vaccine works on its own.
- This new shot will need emergency use authorization from the U.S. Food and Drug Administration prior to rolling out to the public.
Finally, the company will study the variant-specific vaccine but at a higher volume. Again, this will be done to make sure that the Moderna variant booster shot can work on its own and is safe to give out to people.
Moderna said: “Out of an abundance of caution, Moderna is pursuing a clinical development strategy against these emerging variants.”
Moderna said in January it would work on upgrading the COVID-19 vaccine to combat the coronavirus variants so they don’t become more dominant in the U.S., as I wrote for the Deseret News. Moderna said in February it would begin conducting its new trials.